Schrodinger Inc (SDGR)
Schrödinger, Inc. - Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/RefractoryWaldenström Macroglobulinemia
Schrödinger, Inc. - Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/RefractoryWaldenström Macroglobulinemia
Autonomix Medical, Inc. Granted New U.S. Patent for Innovative Catheter-Based Platform Technology
CorMedix Inc. Announces Pricing of Public Offering of Common Stock
Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenström Macroglobulinemia
Calidi Biotherapeutics Announces Shareholder Letter from CEO
HCW Biologics to Showcase Important Updates on IND-Enabling Studies and Preclinical Success of Its Novel Multi-Specific T-Cell Engagers Against Solid Tumors
UTHR: Notification
Danaher Appoints Martin Stumpe as Chief Technology and AI Officer
Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right
Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right